Table 3 Results of univariate and multivariate analyses with hypersensitivity pneumonitis versus other lung diseases

 CD8⁺ (%)

1.02 (1.01–1.04)

0.004

1.03 (1.01–1.04)^a

0.003

 NK (%)

1.28 (1.14–1.45)

< 0.001

1.29 (1.14–1.46)^b

< 0.001

 NKT (%)

1.03 (0.99–1.06)

0.184

1.02 (0.98–1.06)^c

0.386

 CD8⁺ (absolute count)^g

1.02 (1.01–1.03)

< 0.001

1.01 (1.00–1.02)^d

0.070

 NK (absolute count)^g

1.25 (1.12–1.39)

< 0.001

1.15 (1.03–1.29)^e

< 0.001

 NKT (absolute count)^g

1.08 (1.03–1.13)

0.002

1.02 (0.99–1.06)^f

0.241

 CD8⁺ (%)

1.04 (1.03–1.06)

< 0.001

1.05 (1.03–1.07)^a

< 0.001

 NK (%)

1.27 (1.11–1.45)

< 0.001

1.29 (1.12–1.49)^b

< 0.001

 NKT (%)

1.02 (0.98–1.06)

0.282

1.01 (0.97–1.05)^c

0.725

 CD8⁺ (absolute count)^g

1.02 (1.01–1.03)

< 0.001

1.02 (1.00–1.03)^d

0.025

 NK (absolute count)^g

1.21 (1.09–1.35)

< 0.001

1.12 (1.00–1.25)^e

0.055

 NKT (absolute count)^g

1.07 (1.02–1.12)

0.007

1.02 (0.98–1.05)^f

0.410

 CD8⁺ (%)

0.95 (0.94–0.97)

< 0.001

0.95 (0.93–0.97)^a

< 0.001

 NK (%)

0.87 (0.78–0.97)

0.014

0.85 (0.75–0.96)^b

0.010

 NKT (%)

0.99 (0.96–1.03)

0.574

1.00 (0.96–1.04)^c

0.938

 CD8⁺ (absolute count)^g

0.98 (0.97–0.99)

< 0.001

0.98 (0.97–0.99)^d

0.005

 NK (absolute count)^g

0.90 (0.83–0.97)

0.007

0.96 (0.90–1.03)^e

0.239

 NKT (absolute count)^g

0.97 (0.93–1.00)

0.041

0.99 (0.97–1.03)^f

0.993